Deep Margin podcast

Episode 21: Alan Ho live (post hoc) from the Multidisciplinary Head and Neck Cancers Symposium

31/5/2026
0:00
39:56
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Alan Ho, Medical oncologist at MSKCC talks us through his work around Ozuriftamab Vedotin (Oz-V) and other ADC approaches. Ben criticises Will's combination approaches.

Altri episodi di "Deep Margin"